数字技术干预措施对改善轻度认知障碍和痴呆症的认知功能的影响:系统性审查和元分析
1College of Nursing, Pusan National University, Yangsan-si, Gyeongsangnam-do, Republic of Korea.
Research in nursing & health
|April 3, 2024
概括
数字技术干预显著改善了轻度认知障碍和痴呆症患者的认知功能. 本系统性审查提供了使用数字疗法来管理认知衰退的证据.
科学领域:
- 神经科学是一个神经科学.
- 数字健康数字健康
- 老年学是一门学科.
背景情况:
- 数字疗法越来越多地被开发和商业化.
- 认知障碍,包括轻度认知障碍 (MCI) 和痴呆症,对健康构成重大挑战.
- 越来越需要有效的干预措施来管理认知衰退.
研究的目的:
- 系统地审查和元分析数字技术干预措施对MCI和痴呆症患者认知功能的影响.
- 提供支持开发和应用认知健康管理数字干预措施的证据.
主要方法:
- 进行了随机对照试验 (RCT) 的系统审查和元分析.
- 在主要数据库 (PubMed,Embase,Cochrane,CINAHL) 进行了搜索,搜索到2023年4月之前发表的研究.
- 包含12个涉及MCI和痴呆症患者认知功能的数字技术干预的RCT,并使用RevMan 5.4.4进行分析.
主要成果:
- 数字技术干预措施对全球认知功能产生了显著的积极影响 (SMD = 0.31,p = 0.02).
- 在特定的认知领域观察到显著的改善:注意力 (SMD = 1.17,p = 0.004),视觉空间感知 (SMD = 0.68,p = 0.006) 和记忆 (SMD = 0.45,p = 0.0007).
- 分析表明,在一些结果中,异质性中等至高.
结论:
- 数字技术干预在改善轻度认知障碍和痴呆症患者的认知功能方面是有效的.
- 这些发现支持将数字疗法整合到临床实践中,用于管理认知衰退.
- 进一步的研究可能会探索最佳的数字干预设计和长期影响.
相关概念视频
01:30Cognitive Development During Adulthood
96
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
96
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
122
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
122
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
01:22Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
01:26Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469